Brief: Universal Biosensors Got Approval From Indian Central Drugs Standard Control Organisation For Sale Of Xprecia Prime
31/08/2023 03:15
Aug 31 (Reuters) - Universal Biosensors Inc UBI.AX :
* RECEIVED APPROVAL FROM INDIAN CENTRAL DRUGS STANDARD
CONTROL
ORGANISATION FOR SALE OF XPRECIA PRIME
* FIRST ORDER IS IN PROCESS OF BEING DELIVERED AND WILL SEE
FIRST
SALES INTO MARKET IN Q3 CY23
Source text for Eikon: ID:nASX8b3C7j
Further company coverage: UBI.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Universal Biosensors
See all newsBrief: Universal Biosensors Seeks Trading Halt Pending Announcement On Financial Position & Funding
Brief: Universal Biosensors Signs Non-Binding Term Sheet For A$8.5M Funding
Brief: Universal Biosensors Seeks Trading Halt
Brief: Universal Biosensors Inc Posts Qtrly Total Revenue A$1.6 Million
Brief: Universal Biosensors Says John Sharman Steps Down As Managing Director And CEO